Australian (ASX) Stock Market Forum

SNT - Syntara Limited

Joined
1 October 2005
Posts
326
Reactions
0
Looking very nice indeed from a shorter term and longer perspective, so i thought I would open a thread on this one. It is looking very positive on the back of the Phase 111 Clinical trials and technically broke out today to new highs. Will most likely jump on this tommorow for a long term hold.
 

Attachments

  • pxs.gif
    pxs.gif
    21.5 KB · Views: 134
Agree that this most likely will go up oday on yesterday's ann and rise in DJIA.
THe price has almost reached one analyst's indicative price of mid $4 on achieving 10% market by 2010. Though company says it's market target is 30%
 
One I'm adding to the portfolio.

I see this as low risk with Support found around $3.85.
Appears supply has been shaken out and will be looking for an increase in volume with any forward move to convince me to hold.
A convincing break above the recient high would be a strong technical bullish signal.
 

Attachments

  • pxs.gif
    pxs.gif
    36.2 KB · Views: 109
Agree that this most likely will go up oday on yesterday's ann and rise in DJIA.
THe price has almost reached one analyst's indicative price of mid $4 on achieving 10% market by 2010. Though company says it's market target is 30%

Do you know what this company actually does, appears quite unique

Earnings and Dividends Forecast (cents per share)
2007 2008 2009 2010
EPS -13.6 -16.7 10.1 38.7
DPS 0.0 0.0 0.0 0.0


thx

MS
 
Both products Aridol and Bronchitol appear very unique and will hopefully provide a healthy revenue stream in the future.

I purchased some recently at $3.50 feeling I had paid to much however the price has taken off since then. With the option for shareholders to purchase $5000 of securities at $3.90 is anyone planning to take it up?

Should have invested more back in the $2 days :banghead:
 
Fallen from $4.5 to $2.2 in the last six months?? Whats the go?

Bit disappointing, haven't seen it around these levels for around a year and a half. The broker firms are still giving it buying recommendations which can be seen on the company's website.

Thoughts?
 
Fallen from $4.5 to $2.2 in the last six months?? Whats the go?

Bit disappointing, haven't seen it around these levels for around a year and a half. The broker firms are still giving it buying recommendations which can be seen on the company's website.

Thoughts?


I really like this stock. I think the reason why it is falling is that its still a speculative stock as it hasnt got approvals internationally to distribute. I think this is why the share rising to $4-$5 was just overpriced and ur seeing it fall.

It also doesnt help with rising US$ will cut their profits and also with global markets slowing down all stocks take a hammering. However If your abit of a gambler ( i am) its a good buy as it looks to be sold off to much.

The reason are as below( please feel free to disagree with me)
- slow down in markets usually means that companies which are not affected by economic slow downs, such as PXS ( sick patients need drugs)
- I predict that they should have full approvals internationally

It has two main drugs.

Aridol and BRONCHITOL

Aridol is for asthma treatment
Bronchitol is for crystic Fibrosis, Bronchiectasis and Chronic obstruction disease.

Aridol approved in AUS and Sweeden. Waiting for approval for USA and Korea( should know this qaurter, I think we were meant to know by end of feb08 not sure why there is a delay)

Bronchitol got approval in aus and market mid year. USA is in phrase 3 trials should know april 2008.

A new announcement also indicate that Bronchitol is trialed in China will know end of 2008 approx.

Have this stock on your watch list because there should be alot of announcements in March and if they are good that sp of $2.40 should head north

These two drugs are apparently very unique.

This is my :2twocents, These are just my opinons... I just wish that I had $50k in my pocket...

Happy trading :D
 
Future looks rosy, approvals/trials going well all over the world so why the big drop in sp? It's dropped beyond what you'd expect even considering current market conditions & the speculative (less so now) nature of the company.
~$1.80 from highs well over $4:(
 
Reason is the trials needed to be extended for another 12 months for Europe and US. <-- this is by memory read the latest announcement.

My opinion why the price has dropped is purely to do with the extended trials. It basically means they need to spend more money with the trials, This could mean that they are having problems with their drugs( maybe side effects ?)

The drugs therefor are delayed to be produce and that ultimately hurts ur
bottom line.

I believe another reason why the price has dropped was how they announced it. Instead of making a statement about the trials they subtly hide in their quarterly.

Usually the company would announce trials but this time it was a negative update on trials... <-- but hey thats just my view..

;)
 
Reason is the trials needed to be extended for another 12 months for Europe and US. <-- this is by memory read the latest announcement. >>>>>>

>>>>Usually the company would announce trials but this time it was a negative update on trials... <-- but hey thats just my view..

;)

Thanks for that, I read their ann's too but those details snuck past me. (a case of only seeing what I want to see):banghead:
Still huge potential but an extra 12 mths to the ~biggest market is still an extra 12 months of crossed fingers.
 
Thanks for that, I read their ann's too but those details snuck past me. (a case of only seeing what I want to see):banghead:
Still huge potential but an extra 12 mths to the ~biggest market is still an extra 12 months of crossed fingers.

Yeh PXS got hammered for it. It is a real shame, i thought the trials would do really well.... i suppose this is what happens with specs, put it in ur bottom drawer and bring it out next year and see how u go :)
 
Pharmaxis is heading in the right direction again. The last 2 months while ignoring the rest of the market. Pharmaxis news certainly looks rosy.
pxs_ax13mar08_to_21sep08.png
 
Pharmaxis is heading in the right direction again. The last 2 months while ignoring the rest of the market. Pharmaxis news certainly looks rosy.
View attachment 23798

Hm its not too bad, although it appears its not earnings positive as yet

Earnings and Dividends Forecast (cents per share)
2008 2009 2010 2011
EPS -10.8 -13.7 -5.6 19.8
DPS 0.0 0.0 0.0 0.0


thx

MS
 
Hm its not too bad, although it appears its not earnings positive as yet


MS

Most definitely quite risky, typical biotech something could go terribly wrong at the last hurdle but PXS isn't depending on just one or two products & they all have the promise of big bucks in the long run. Biotechs like this take as long or longer than mines to get off the ground.
IMO though I think this is as close as a sure thing as you can get in a biotech simply because of the number of products & the positive results so far including there first product already approved in a lot of countries. Don't take my word for it I don't have a clue, just read there announcements through ASX.:)
 
G'day,

How do I find out how much cash pharmaxis has??

Pharmaxis has held up pretty well in the last month or so considering the market downturn.

Also saw on another site that huntleys brought out a reccomendation/report

cheers
 
Try their website. As a shareholder I get their quarterly reports which are very informative.
pxs_ax02apr08_to_10oct08.png

With the market the way it is at the moment there may be another chance to get in at a lower price than today. I'm waiting to top up if the price drops again.:2twocents
 
pxs_ax18apr08_to_28oct08.png
AHEM!

Like the rest of the market, it's either a good buy or still waiting for the bottom.:(
 
Trading Halt! to raise capital, recently US FDA Accepted Aridol New Drug Application for Review so they probably need capital for expansion/ drug release in the US. All will be revealed when they make their next ann. & the trading halt is finished.
How will this affect the sp I wonder! :confused:
 
Trading Halt! to raise capital, recently US FDA Accepted Aridol New Drug Application for Review so they probably need capital for expansion/ drug release in the US. All will be revealed when they make their next ann. & the trading halt is finished.
How will this affect the sp I wonder! :confused:

Just thinking yesterday how boring this stock was getting having held my entitlement since June, a very long sideways Pennant. Since the rest of the mkt is moving I could have been making money elsewhere- then - along comes todays Quarterly & the sp bounces up to $2.44 :D
I think I should just accumulate this one for a few more years while I play weekly trading with other stocks in the "BULL" market. PXS can be my retirement package :)
pxs_ax15apr09_to_23oct09.png
DYOR this is a fundamentals based decision on a Bio speccy, not my usual quick dash for cash ;)
 
Top